Azra H. Ligon
- Genetics top 0.2%
- Glioma Diagnosis and Treatment 29
- Oncology top 0.2%
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 10
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 12
- Immunology top 1%
-
- Sarcoma Diagnosis and Treatment 9
-
- Uterine Myomas and Treatments 9
-
- Meningioma and schwannoma management 7
-
- Neurofibromatosis and Schwannoma Cases 7
-
- Microtubule and mitosis dynamics 6
- Co-authors
- Scott J. RodigMargaret A. ShippPhilippe ArmandBjoern ChapuyGordon J. FreemanMark A. PershouseW.K. Alfred YungStephen M. Ansell
- Journals
- Genes Chromosomes and Cancer (7 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Azra H. Ligon
87 papers receiving 11.3k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Genetics 2.2k
- Oncology 4.9k
- Pathology and Forensic Medicine 2.7k
- Cancer Research 1.7k
- Immunology 2.2k
Countries citing papers authored by Azra H. Ligon
This map shows the geographic impact of Azra H. Ligon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azra H. Ligon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azra H. Ligon more than expected).
Fields of papers citing papers by Azra H. Ligon
This network shows the impact of papers produced by Azra H. Ligon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azra H. Ligon. The network helps show where Azra H. Ligon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Azra H. Ligon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2020 | 3 | |
| 3 | 2019 | 13 | |
| 4 | 2016 | 139 | |
| 5 | 2016 | 88 | |
| 6 | 2015 | 81 | |
| 7 | 2015 | 63 | |
| 8 | 2014 | 211 | |
| 9 | 2014 | 25 | |
| 10 | 2014 | 2 | |
| 11 | EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing | 2014 | 12 |
| 12 | 2014 | 4 | |
| 13 | 2013 | 132 | |
| 14 | 2012 | 20 | |
| 15 | 2011 | 64 | |
| 16 | Recurrent BRAF mutations in Langerhans cell histiocytosisbreakdown → | 2010 | 742 |
| 17 | 2010 | 139 | |
| 18 | 2010 | 44 | |
| 19 | 2009 | 67 | |
| 20 | 2008 | 456 |
About Azra H. Ligon
Azra H. Ligon is a scholar working on Genetics, Cancer Research and Obstetrics and Gynecology, having authored 89 papers that have together received 11.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (29 papers), Cancer Genomics and Diagnostics (12 papers), Lymphoma Diagnosis and Treatment (10 papers), Sarcoma Diagnosis and Treatment (9 papers), Uterine Myomas and Treatments (9 papers), Meningioma and schwannoma management (7 papers), Neurofibromatosis and Schwannoma Cases (7 papers) and Microtubule and mitosis dynamics (6 papers). The work is most often cited by research in Genetics (2.2k citations), Oncology (4.9k citations) and Pathology and Forensic Medicine (2.7k citations). Azra H. Ligon has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Scott J. Rodig, Margaret A. Shipp, Philippe Armand, Bjoern Chapuy, Gordon J. Freeman, Mark A. Pershouse, W.K. Alfred Yung, Stephen M. Ansell, John M. Timmerman and Peter A. Steck. Their work appears in journals such as Genes Chromosomes and Cancer, Journal of Clinical Oncology, Clinical Cancer Research, Neuro-Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.